...
首页> 外文期刊>Experimental Eye Research >Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation invitro: A potentially novel therapy for corneal scarring
【24h】

Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation invitro: A potentially novel therapy for corneal scarring

机译:亲电性PPARγ配体可抑制角膜成纤维细胞向成纤维细胞的体外分化:角膜瘢痕形成的潜在新疗法

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A critical component of corneal scarring is the TGFβ-induced differentiation of corneal keratocytes into myofibroblasts. Inhibitors of this differentiation are potentially therapeutic for corneal scarring. In thisstudy, we tested the relative effectiveness and mechanisms of action of two electrophilic peroxisome proliferator-activated receptor gamma (PPARγ) ligands: cyano-3,12-dioxolean-1,9-dien-28-oic acid-methyl ester (CDDO-Me) and 15-deoxy-Δ -12,14-prostaglandin J 2 (15d-PGJ 2) for inhibiting TGFβ-induced myofibroblast differentiation invitro. TGFβ was used to induce myofibroblast differentiation in cultured, primary human corneal fibroblasts. CDDO-Me and 15d-PGJ 2 were added to cultures to test their ability to inhibit this process. Myofibroblast differentiation was assessed by measuring the expression of myofibroblast-specific proteins (αSMA, collagen I, and fibronectin) and mRNA (αSMA and collagen III). The role of PPARγ in the inhibition of myofibroblast differentiation by these agents was tested in genetically and pharmacologically manipulated cells. Finally, we assayed the importance of electrophilicity in the actions of these agents on TGFβ-induced αSMA expression via Western blotting and immunofluorescence. Both electrophilic PPARγ ligands (CDDO-Me and 15d-PGJ 2) potently inhibited TGFβ-induced myofibroblast differentiation, but PPARγ was only partially required for inhibition of myofibroblast differentiation by either agent. Electrophilic PPARγ ligands were able to inhibit myofibroblast differentiation more potently than non-electrophilic PPARγ ligands, suggesting an important role of electrophilicity in this process. CDDO-Me and 15d-PGJ 2 are strong inhibitors of TGFβ-induced corneal fibroblast to myofibroblast differentiation invitro, suggesting this class of agents as potential novel therapies for corneal scarring warranting further study in pre-clinical animal models.
机译:角膜瘢痕形成的关键组成部分是TGFβ诱导的角膜角膜细胞分化为成肌纤维细胞。这种分化的抑制剂可能对角膜瘢痕形成治疗。在这项研究中,我们测试了两种亲电性过氧化物酶体增殖物激活受体γ(PPARγ)配体的相对有效性和作用机理:氰基-3,12-二氧杂环戊烷-1,9-dien-28-乙酸甲酯(CDDO- Me)和15-deoxy-Δ-12,14-前列腺素J 2(15d-PGJ 2)抑制TGFβ诱导的肌成纤维细胞体外分化。 TGFβ被用于诱导培养的人原代角膜成纤维细胞中成肌纤维细胞的分化。将CDDO-Me和15d-PGJ 2添加到培养物中以测试其抑制该过程的能力。通过测量成肌纤维细胞特异性蛋白(αSMA,胶原蛋白I和纤连蛋白)和mRNA(αSMA和胶原蛋白III)的表达来评估成肌纤维细胞的分化。在遗传和药理学控制的细胞中测试了PPARγ在抑制这些成纤维细胞分化中的作用。最后,我们通过蛋白质印迹和免疫荧光分析了亲电性在这些药物对TGFβ诱导的αSMA表达的作用中的重要性。两种亲电性PPARγ配体(CDDO-Me和15d-PGJ 2)均能有效抑制TGFβ诱导的成肌纤维细胞分化,但是PPARγ仅是部分抑制任一种成肌纤维细胞分化的必需物质。亲电的PPARγ配体比非亲电的PPARγ配体能够更有效地抑制成肌纤维细胞分化,表明亲电在此过程中起着重要的作用。 CDDO-Me和15d-PGJ 2是TGFβ诱导的角膜成纤维细胞体外成肌细胞分化的强抑制剂,这表明这类药物作为角膜瘢痕形成的潜在新疗法值得在临床前动物模型中进行进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号